Assert-IQ vs V7 Diagnostic Ultrasound System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Assert-IQ

by Abbott

V7 Diagnostic Ultrasound System

by Samsung Healthcare

AI Verdict

These two tools are adjacent in their comparability, both offering AI-powered solutions within cardiology, but with distinct approaches. Assert-IQ focuses on long-term, continuous cardiac monitoring through an insertable device for arrhythmia detection. In contrast, the V7 Diagnostic Ultrasound System is a versatile ultrasound scanner providing real-time diagnostic imaging across multiple specialties, including cardiovascular, with AI features for image enhancement and automated measurements.

Choose Assert-IQ if…

Choose Assert-IQ if you need long-term, continuous cardiac monitoring for patients with suspected or diagnosed heart rhythm disorders, especially for detecting infrequent or asymptomatic arrhythmias like atrial fibrillation. Its minimally invasive insertion and remote monitoring capabilities allow for extended diagnostic evaluation and management of conditions causing symptoms such as dizziness, palpitations, or syncope.

View Assert-IQ →

Choose V7 Diagnostic Ultrasound System if…

Choose the Samsung V7 Diagnostic Ultrasound System if you require a versatile, high-performance imaging solution for a broad range of clinical applications, including women's health, general imaging, and cardiovascular assessments. Its AI-powered tools and advanced imaging technology are ideal for enhancing diagnostic precision and workflow efficiency in diverse and complex cases, such as automated fetal biometry or quantitative tissue stiffness assessment.

View V7 Diagnostic Ultrasound System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Assert-IQ	V7 Diagnostic Ultrasound System
Deployment	Subcutaneously implanted device with mobile app connectivity	On-premise (trolley-mounted system)
FDA Status	Cleared AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

V7 Diagnostic Ultrasound System

The Samsung V7 Diagnostic Ultrasound System emphasizes a redesigned workflow for simplicity and efficiency, aiming to reduce tasks to fewer steps or keystrokes. User testimonials also highlight its intuitive operation. In contrast, Assert-IQ focuses on remote monitoring and data transmission, which, while convenient, doesn't inherently suggest a simpler user interface for the core clinical task.

Clinical Value

V7 Diagnostic Ultrasound System

The Samsung V7 offers a broader range of AI-powered diagnostic features across multiple specialties (women's health, general imaging, cardiovascular), including automated measurements and enhanced imaging technologies for clearer diagnoses. Assert-IQ, while providing long-term cardiac monitoring and advanced arrhythmia detection, is more specialized in its application.

Pricing & Value

Tie

Both tools require contacting the company for pricing details, making direct comparison difficult. Neither provides transparent pricing information upfront. While the V7 has a price range listed on a third-party marketplace, this is not official pricing from the manufacturer.

Enterprise Readiness

Assert-IQ

Assert-IQ is specifically designed for large health systems, hospitals, and cardiology clinics, offering secure cloud-based data, remote monitoring, and proactive clinician alerts, indicating a robust infrastructure for enterprise deployment. The V7 is an on-premise hardware solution, which, while powerful, may require more localized management and integration efforts within a large enterprise.

Innovation

V7 Diagnostic Ultrasound System

The Samsung V7 showcases a wider array of AI-powered intelligent assist features for diagnostic precision and workflow efficiency across diverse imaging applications, such as automated fetal biometry and uterine measurements, and advanced imaging architecture. Assert-IQ's innovation primarily lies in its long-term, continuous cardiac monitoring with advanced arrhythmia detection algorithms and remote programming capabilities.

Support & Docs

Tie

Neither the provided structured facts nor web searches offer specific details about the breadth or accessibility of support and documentation for either product. Both are from established medical device companies, suggesting a baseline level of support, but no distinguishing factors are apparent.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Assert-IQ	V7 Diagnostic Ultrasound System
Tool Name	Assert-IQ	V7 Diagnostic Ultrasound System
Company	Abbott Medical	Samsung Medison Co.
Description	The Assert-IQu2122 Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders.	The Samsung V7 Diagnostic Ultrasound System is a high-performance, versatile ultrasound scanner featuring AI-powered tools and advanced imaging technology for superior diagnostic capabilities across women's health, general imaging, and cardiovascular applications.
Key Features	Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission, Secure cloud-based data platform, Remote monitoring capabilities, Proactive clinician alerts, Patient activator for symptom logging, Minimally invasive insertion	Crystal Architectureu2122 (CrystalBeamu2122, CrystalLiveu2122) for enhanced 2D, 3D, and color imaging, AI-Powered Intelligent Assist features for diagnostic precision and workflow efficiency, BiometryAssistu2122 for automated fetal biometry measurements, 5D Heart Coloru2122 for semi-automated fetal heart evaluation, UterineAssistu2122 for automated uterine size and shape measurements using Deep Learning, S-Shearwave Imagingu2122 for quantitative, non-invasive assessment of tissue stiffness (e.g., breast, liver), ShadowHDRu2122 for improved visualization in shadowed regions, MV-Flowu2122 for detailed visualization of microvascular perfusion

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and V7 Diagnostic Ultrasound System.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

Assert-IQ is designed to streamline workflow by reducing false positives through AI algorithms, which means less time reviewing non-actionable transmissions. It also offers remote programming capabilities, allowing clinicians to adjust device settings without in-person patient visits. The V7 Ultrasound System focuses on workflow efficiency with features like EzExam+u2122 and EzCompareu2122 to minimize steps and keystrokes, and a customizable touchscreen for frequently used functions. While Assert-IQ transmits data to a cloud-based platform, the V7 system's on-premise deployment and embedded browser for RIS access suggest a different approach to data flow within the clinic.

What is the accuracy and sensitivity of each tool, particularly concerning their AI-powered features?

Assert-IQ ICM with AI maintains 100% patient sensitivity for pause and AF, while reducing false positives for pause episodes by 91% and AF by 81%. A study showed Assert-IQ achieved 99.4% episode-based sensitivity for AF, with AI retaining all true episodes and delivering a 94% positive predictive value for AF episodes. The V7 Ultrasound System features AI-powered tools like BiometryAssistu2122 for automated fetal biometry and UterineAssistu2122 for automated uterine measurements, enhancing diagnostic precision. Its Crystal Architectureu2122 and advanced imaging technologies aim for superior diagnostic capabilities across various applications.

Given their specialized applications, what is the learning curve for physicians and sonographers to effectively use these tools?

The Assert-IQ ICM aims to reduce data burden and improve clinical efficiency through its AI algorithms, suggesting a focus on simplifying data interpretation for clinicians. Abbott also provides SyncUPu2122 Remote Monitoring Support for patient education and setup of the myMerlinu2122 Mobile App, which could ease the learning curve for patients and indirectly for clinicians managing remote monitoring. The V7 Ultrasound System is designed with an intuitive and ergonomic interface, including a touch-based control panel and streamlined user interface, to simplify adjustments and image review, which could contribute to a shorter learning curve.

What kind of support and training are available to ensure optimal utilization and address technical issues?

Abbott offers SyncUPu2122 Remote Monitoring Support for Assert-IQ, providing one-on-one education sessions for patients on app usage and remote monitoring functions, and weekly compliance reports for clinics. This support aims to streamline remote monitoring efforts and improve patient outcomes. For the V7 Ultrasound System, while not explicitly detailed in the provided information, the focus on an intuitive and ergonomic design, along with features like customizable touchscreens, suggests an emphasis on user-friendliness that could reduce the need for extensive support.

Are there audit-trail features available to track access, changes, and interpretations of patient data?

The provided information for Assert-IQ mentions remote programming and data transmission to the Merlin.netu2122 Patient Care Network, implying a system for managing and reviewing patient data, but specific audit-trail features are not detailed. Similarly, for the V7 Ultrasound System, while it emphasizes workflow efficiency and diagnostic precision, explicit audit-trail features for tracking data access, changes, or interpretations are not specified in the provided text.

How do these tools facilitate multi-site rollouts and consistent implementation across different clinical settings?

Assert-IQ's remote monitoring and programming capabilities, along with its cloud-based data platform, could facilitate multi-site rollouts by centralizing data management and allowing for consistent device settings across various locations without requiring extensive on-site presence. The V7 Ultrasound System, being an on-premise hardware solution, would likely involve individual unit deployment and configuration at each site. However, its standardized AI-powered features and intuitive interface could contribute to consistent usage and diagnostic approaches across different clinical settings.